Two Sigma Advisers’s Catalyst Pharmaceutical CPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-10,892
| Closed | -$217K | – | 2369 |
|
|
2024
Q3 | $217K | Buy |
+10,892
| New | +$217K | ﹤0.01% | 2037 |
|
|
2023
Q3 | – | Sell |
-633,392
| Closed | -$8.51M | – | 2420 |
|
|
2023
Q2 | $8.51M | Sell |
633,392
-944,300
| -60% | -$12.7M | 0.02% | 557 |
|
|
2023
Q1 | $26.2M | Sell |
1,577,692
-233,300
| -13% | -$3.87M | 0.07% | 267 |
|
|
2022
Q4 | $33.7M | Buy |
1,810,992
+207,500
| +13% | +$3.86M | 0.09% | 214 |
|
|
2022
Q3 | $20.6M | Buy |
1,603,492
+526,200
| +49% | +$6.75M | 0.06% | 314 |
|
|
2022
Q2 | $7.55M | Sell |
1,077,292
-156,700
| -13% | -$1.1M | 0.02% | 600 |
|
|
2022
Q1 | $10.2M | Buy |
1,233,992
+342,800
| +38% | +$2.84M | 0.03% | 512 |
|
|
2021
Q4 | $6.03M | Buy |
891,192
+485,000
| +119% | +$3.28M | 0.02% | 684 |
|
|
2021
Q3 | $2.15M | Sell |
406,192
-284,000
| -41% | -$1.51M | 0.01% | 1207 |
|
|
2021
Q2 | $3.97M | Sell |
690,192
-206,400
| -23% | -$1.19M | 0.01% | 965 |
|
|
2021
Q1 | $4.13M | Buy |
896,592
+168,200
| +23% | +$775K | 0.01% | 931 |
|
|
2020
Q4 | $2.43M | Sell |
728,392
-5,900
| -0.8% | -$19.7K | 0.01% | 1150 |
|
|
2020
Q3 | $2.18M | Sell |
734,292
-360,300
| -33% | -$1.07M | 0.01% | 1119 |
|
|
2020
Q2 | $5.06M | Buy |
1,094,592
+653,400
| +148% | +$3.02M | 0.01% | 790 |
|
|
2020
Q1 | $1.7M | Sell |
441,192
-15,900
| -3% | -$61.2K | 0.01% | 1202 |
|
|
2019
Q4 | $1.71M | Buy |
457,092
+444,200
| +3,446% | +$1.67M | ﹤0.01% | 1294 |
|
|
2019
Q3 | $68K | Buy |
+12,892
| New | +$68K | ﹤0.01% | 2137 |
|
|
2019
Q1 | – | Sell |
-10,000
| Closed | -$19K | – | 2319 |
|
|
2018
Q4 | $19K | Sell |
10,000
-48,200
| -83% | -$91.6K | ﹤0.01% | 2312 |
|
|
2018
Q3 | $220K | Sell |
58,200
-28,400
| -33% | -$107K | ﹤0.01% | 2055 |
|
|
2018
Q2 | $270K | Buy |
86,600
+20,300
| +31% | +$63.3K | ﹤0.01% | 2132 |
|
|
2018
Q1 | $158K | Sell |
66,300
-11,792
| -15% | -$28.1K | ﹤0.01% | 2175 |
|
|
2017
Q4 | $305K | Buy |
+78,092
| New | +$305K | ﹤0.01% | 1939 |
|